Abstract
The serum precursor SAA of the secondary amyloid protein AA has been detected by solid-phase radioimmunoassay as a normal serum alpha- globulin of mol wt 160,000, which dissociates to a more stable 12,500 dalton moiety on treatment with formic acid. In 12 strains of mice, including T-cell-deficient nude mice, treated with the amyloid-inducing agents lipopolysaccharide (LPS) or casein, SAA behaved as an acute- phase reactant. SAA concentration rose to about 750 mug/ml by 24 h and returned to less than 1 mug/ml by 48 h. Since the amyloid-resistant colchicine-treated mice and AJ mice had a normal SAA response to LPS, it appears that their resistance to amyloid induction is due to the nature of their SAA processing rather than decreased SAA production. C3H/HeJ mice, which have defective B-lymphocyte responses to LPS, required extremely high dosages of LPS to cause SAA elevation, although their SAA response to casein was normal. This suggests that SAA is an acute-phase protein produced as a result of B-lymphocyte stimulation. Preliminary evidence suggests that at the height of an acute SAA response, liver homogenates are particularly rich in protein AA cross- reacting material.
Full Text
The Full Text of this article is available as a PDF (480.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anders R. F., Natvig J. B., Michaelsen T. E., Husby G. Isolation and characterization of amyloid-related serum protein SAA as a low molecular weight protein. Scand J Immunol. 1975;4(4):397–401. doi: 10.1111/j.1365-3083.1975.tb02642.x. [DOI] [PubMed] [Google Scholar]
- Anders R. F., Nordstoga K., Natvig J. B., Husby G. Amyloid-related serum protein SAA in endotoxin-induced amyloidosis of the mink. J Exp Med. 1976 Mar 1;143(3):678–683. doi: 10.1084/jem.143.3.678. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Benson M. D., Aldo-Benson M. A., Shirahama T., Borel Y., Cohen A. S. Suppression of in vitro antibody response by a serum factor (SAA) in experimentally induced amyloidosis. J Exp Med. 1975 Jul 1;142(1):236–241. doi: 10.1084/jem.142.1.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Britton S. Experimental amyloidosis: the inducer is a polyclonal B-cell activator to which susceptibility is under genetic control. J Exp Med. 1975 Dec 1;142(6):1564–1569. doi: 10.1084/jem.142.6.1564. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eriksen N., Ericsson L. H., Pearsall N., Lagunoff D., Benditt E. P. Mouse amyloid protein AA: Homology with nonimmunoglobulin protein of human and monkey amyloid substance. Proc Natl Acad Sci U S A. 1976 Mar;73(3):964–967. doi: 10.1073/pnas.73.3.964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Glenner G. G., Page D., Isersky C., Harada M., Cuatrecasas P., Eanes E. D., DeLellis R. A., Bladen H. A., Keiser H. R. Murine amyloid fibril protein: isolation, purification and characterization. J Histochem Cytochem. 1971 Jan;19(1):16–28. doi: 10.1177/19.1.16. [DOI] [PubMed] [Google Scholar]
- Isersky C., Page D. L., Cuatrecasas P., DeLellis R. A., Glenner G. G. Murine amyloidosis: immunologic characterization of amyloid fibril protein. J Immunol. 1971 Dec;107(6):1690–1698. [PubMed] [Google Scholar]
- Kedar I., Ravid M., Sohar E., Gafni J. Colchicine inhibition of casein-induced amyloidosis in mice. Isr J Med Sci. 1974 Jul;10(7):787–789. [PubMed] [Google Scholar]
- McAdam K. P., Anders R. F., Smith S. R., Russell D. A., Price M. A. Association of amyloidosis with erythema nodosum leprosum reactions and recurrent neutrophil leucocytosis in leprosy. Lancet. 1975 Sep 27;2(7935):572–573. doi: 10.1016/s0140-6736(75)90168-3. [DOI] [PubMed] [Google Scholar]
- Morrison D. C., Betz S. J., Jacobs D. M. Isolation of a lipid A bound polypeptide responsible for "LPS-initiated" mitogenesis of C3H/HeJ spleen cells. J Exp Med. 1976 Sep 1;144(3):840–846. doi: 10.1084/jem.144.3.840. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosenthal C. J., Franklin E. C., Frangione B., Greenspan J. Isolation and partial characterization of SAA-an amyloid-related protein from human serum. J Immunol. 1976 May;116(5):1415–1418. [PubMed] [Google Scholar]
- Rosenthal C. J., Franklin E. C. Variation with age and disease of an amyloid A protein-related serum component. J Clin Invest. 1975 Apr;55(4):746–753. doi: 10.1172/JCI107985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scheinberg M. A., Cathcart E. S. Casein-induced experimental amyloidosis. III. Response to mitogens, allogeneic cells, and graft-versus-host reactions in the murine model. Immunology. 1974 Nov;27(5):953–963. [PMC free article] [PubMed] [Google Scholar]
- Shirahama T., Cohen A. S. Blockage of amyloid induction by colchicine in an animal model. J Exp Med. 1974 Oct 1;140(4):1102–1107. doi: 10.1084/jem.140.4.1102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sipe J. D., Ignaczak T. F., Pollock P. S., Glenner G. G. Amyloid fibril protein AA: purification and properties of the antigenically related serum component as determined by solid phase radioimmunoassay. J Immunol. 1976 Apr;116(4):1151–1156. [PubMed] [Google Scholar]
- Skidmore B. J., Morrison D. C., Chiller J. M., Weigle W. O. Immunologic properties of bacterial lipopolysaccharide (LPS). II. The unresponsiveness of C3H/HeJ Mouse spleen cells to LPS-induced mitogenesis is dependent on the method used to extract LPS. J Exp Med. 1975 Dec 1;142(6):1488–1508. doi: 10.1084/jem.142.6.1488. [DOI] [PMC free article] [PubMed] [Google Scholar]